CLINICAL_TRIALS
trial_result
· 2013-12-04
Clinical Trial Update: Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis [Phase 3]
Summary
Phase 3 trial comparing etoricoxib 30 mg to celecoxib 200 mg in Korean participants with osteoarthritis shows safety and efficacy data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2013-12-04